10 results
#Pathophys #Neuro #MultipleSclerosis #Topography #NEJM
#Pathophys #Neuro ... MultipleSclerosis #Topography #NEJM
Approaches to Evaluating Kidney Disease in Patients with HIV Infection #Pathophys #Nephro #IM #HIV #CKD #AKI
HIV Infection #Pathophys ... #Nephro #IM #HIV ... #CKD #AKI #NEJM
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
and Indications #Pathophys ... Management #EM #IM ... Catecholamine #Comparison #Table
Algorithm and Differential Diagnosis of Tremor #Diagnosis #IM #PrimaryCare #Neuro #Tremor #Action #Rest #Differential #Algorithm #Comparison
Tremor #Diagnosis #IM ... #PrimaryCare #Neuro ... Algorithm #Comparison #Table
Cells, Molecules, and Therapies. Shown is a simplified schematic depiction of major cell types within white-matter
#Pathophys #Neuro ... DiseaseModifying #Targets #NEJM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
PrimaryCare #EM #IM ... Lightheadedness #Table ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
End Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Trial Group #EBM #Neuro ... #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
End Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Six Trials of Patent Foramen Ovale Closure for Stroke with Results Published in the Journal. #EBM
#EBM #Neuro #Cardiology ... EvidenceSummary #Table ... #NEJM